The forecasted use of antidepressant medicine in France indicates a steady increase from 2024 to 2028, with daily dosage per thousand persons rising from 61.7 in 2024 to 66.6 in 2028. In 2023, the usage stood at 60.4, highlighting a continuous upward trend. Year-on-year growth rates suggest consistent increases, with a compound annual growth rate (CAGR) of approximately 2% observed over the forecast period. This suggests a persistent demand for antidepressants in response to societal and healthcare trends.

Future trends to watch for include:

Potential impacts of mental health awareness initiatives and policy changes on antidepressant usage.
The influence of new pharmaceutical developments or alternatives.
Societal and economic factors affecting mental health issues.